Estimating the impact of imported malaria on local transmission in a near elimination setting: a case study from Bhutan

IF 5 Q1 HEALTH CARE SCIENCES & SERVICES The Lancet regional health. Southeast Asia Pub Date : 2024-10-15 DOI:10.1016/j.lansea.2024.100497
{"title":"Estimating the impact of imported malaria on local transmission in a near elimination setting: a case study from Bhutan","authors":"","doi":"10.1016/j.lansea.2024.100497","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Bhutan has achieved a substantial reduction in both malaria morbidity and mortality over the last two decades and is aiming for malaria elimination certification in 2025. However, a significant percentage of malaria cases in Bhutan are imported (acquired in another country). The aim of the study was to understand how importation drives local malaria transmission in Bhutan.</div></div><div><h3>Methods</h3><div>Information on geo-located individual-level laboratory-confirmed malaria cases between 2016 and 2020 was obtained from the Bhutan Vector-borne Disease Control Program. Records included the date of diagnosis and treatment, type of cases classified as indigenous or imported, and malaria species. Hawkes Processes were used to study the role of imported malaria in local transmission in Bhutan. We imposed 15 days delay for a mosquito to become infectious in the model.</div></div><div><h3>Findings</h3><div>There were 285 cases during the study period and 58.6% (159) were imported malaria. 71.1% (113) of these imported cases were <em>Plasmodium vivax</em> and 73.6% (117) were from India. The model suggested that a person remains infectious for 8 days for <em>Plasmodium falciparum</em> malaria but over 19 days for <em>P. vivax.</em> The background intensity from imported malaria cases was much greater for <em>P. vivax</em> cases (maximum 0.17) resulting in more importations than <em>P. falciparum</em> cases (maximum 0.06). However, model fitting suggested that local <em>P. falciparum</em> transmission was mainly driven by importations but additional factors such as relapse played a role for <em>P. vivax</em>.</div></div><div><h3>Interpretation</h3><div>Imported malaria cases are key drivers of transmission within Bhutan, with most cases since 2016 being <em>P. vivax</em>. Control programmes should be devised to target interventions towards the <em>P. vivax</em> strain and test those who are more likely to bring in imported malaria cases or acquire it from returning travellers.</div></div><div><h3>Funding</h3><div>None.</div></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":null,"pages":null},"PeriodicalIF":5.0000,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet regional health. Southeast Asia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772368224001471","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Bhutan has achieved a substantial reduction in both malaria morbidity and mortality over the last two decades and is aiming for malaria elimination certification in 2025. However, a significant percentage of malaria cases in Bhutan are imported (acquired in another country). The aim of the study was to understand how importation drives local malaria transmission in Bhutan.

Methods

Information on geo-located individual-level laboratory-confirmed malaria cases between 2016 and 2020 was obtained from the Bhutan Vector-borne Disease Control Program. Records included the date of diagnosis and treatment, type of cases classified as indigenous or imported, and malaria species. Hawkes Processes were used to study the role of imported malaria in local transmission in Bhutan. We imposed 15 days delay for a mosquito to become infectious in the model.

Findings

There were 285 cases during the study period and 58.6% (159) were imported malaria. 71.1% (113) of these imported cases were Plasmodium vivax and 73.6% (117) were from India. The model suggested that a person remains infectious for 8 days for Plasmodium falciparum malaria but over 19 days for P. vivax. The background intensity from imported malaria cases was much greater for P. vivax cases (maximum 0.17) resulting in more importations than P. falciparum cases (maximum 0.06). However, model fitting suggested that local P. falciparum transmission was mainly driven by importations but additional factors such as relapse played a role for P. vivax.

Interpretation

Imported malaria cases are key drivers of transmission within Bhutan, with most cases since 2016 being P. vivax. Control programmes should be devised to target interventions towards the P. vivax strain and test those who are more likely to bring in imported malaria cases or acquire it from returning travellers.

Funding

None.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在接近消灭疟疾的环境中估算输入性疟疾对当地传播的影响:不丹的案例研究
背景不丹在过去二十年里大幅降低了疟疾发病率和死亡率,并力争在 2025 年获得消灭疟疾认证。然而,不丹的疟疾病例中有很大一部分是输入性病例(从其他国家感染)。该研究旨在了解输入性疟疾是如何推动不丹当地疟疾传播的。研究方法从不丹病媒传播疾病控制项目中获取了 2016 年至 2020 年期间经实验室确诊的疟疾病例的地理位置信息。记录包括诊断和治疗日期、本地或输入病例类型以及疟疾种类。霍克斯过程用于研究输入性疟疾在不丹本地传播中的作用。我们在模型中设定了蚊子感染的 15 天延迟时间。研究结果在研究期间共有 285 例病例,58.6%(159 例)为输入性疟疾。在这些输入病例中,71.1%(113 例)为间日疟原虫,73.6%(117 例)来自印度。模型显示,恶性疟原虫疟疾的感染期为 8 天,而间日疟原虫疟疾的感染期超过 19 天。输入性疟疾病例的背景强度(最大值为 0.17)远高于恶性疟原虫病例(最大值为 0.06),从而导致输入性疟疾病例的增加。然而,模型拟合表明,当地恶性疟原虫传播主要由输入病例驱动,但复发等其他因素也对间日疟原虫传播起了作用。应制定控制计划,针对间日疟原虫菌株采取干预措施,并对那些更有可能带来输入性疟疾病例或从回国旅行者那里感染间日疟原虫的人进行检测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
0
期刊最新文献
One health intervention for the control and elimination of scrub typhus, anthrax, and brucellosis in Southeast Asia: a systematic review Point of care lactate for differentiating septic shock from hypovolemic shock in non-ICU settings: a prospective observational study Assessment of public health laboratory preparedness and response in WHO South-East Asia region during the COVID-19 pandemic: lessons learned and future directions Advancing evidence-based decision-making in Bhutan: development of a health technology assessment framework The implications of waiving local clinical trials for drugs in India: a double-edged sword?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1